Ledning och VD

This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.

Pontus Nobréus

Pontus Nobréus

CEO

Previous positions: Pontus has held leading business positions in diagnostics and medtech for more than 15 years, including employments in the United States and South Africa. He joins Redsense from a position as CEO of Pro Health Pharma Sweden AB. Pontus has previously served as CEO of Glycorex Transplantation AB (publ) and prior to that as Business Development Director at Biovica International AB. He has also worked at HemoCue and Svar Life Science, and his experience extends across sales, channel management, business development, and marketing in international settings.

Pontus holds an MBA from Henley Business School as well as a M.Sc. in Mechanical Engineering from Lund University. In addition, he is a Certified Board Member by StyrelseAkademien.

Current position: CEO of Redsense Medical AB and Redsense Medical Inc.

Shareholding: 40 000 stock options and 3 300 shares

Brendan Kane

Brendan Kane

U.S. Director of Sales

Joined: January 2016

Previous positions: Has more than 25 years of renal industry experience. Has held various sales, sales management, and business development positions with National Medical Care, Fresenius Medical Care, American Renal Associates and other renal equipment and pharmaceutical manufacturers.

Current position: U.S. Director of Sales

Shareholding: 50 000 shares

Jane Hurst

Jane Hurst

U.S. Clinical Director

Joined:

Previous positions: Started as a nurse in 1980, Jane’s experience covers a wide range of medical specialties including nephrology, hemodialysis, burns and oncology. In 2002, she obtained a certification to consult nursing issues in the judiciary; providing medical-legal knowledge to prosecutors, insurance companies, businesses and governments. For 12 years, Jane has taught a national (USA) certification program for consultants in legal-medical issues and mentored other legal-medical consultants. In addition to her work with Redsense, she still consults in legal-medical matters and has clients across the United States.

Current position: U.S. Clinical Director

Shareholding: 105 000 shares

Sebastien Bollue

Sebastien Bollue

COO

Joined: June 2016

Previous positions: Sebastien joined the Company in 2016, first in the role as Commercial Operations Manager and then as Director of Commercial Operations. His primary task at the Company is to oversee the supply chain and day-to-day commercial operations. He also has solid experience developing and managing distribution relations as well as to coordinate marketing and clinical evaluations.

Current Position: Director Commercial Operations

Shareholding: 50 000 shares

Ann-Marie Eriksson

Ann-Marie Eriksson

CTO

Joined: January 2020

Previous positions: Joining the Company as new CTO in late 2019, Anne-Marie is the most recent addition to the Company’s executive management. Ann-Marie Eriksson holds a Master of Science in Electrical Engineering with specialization in signal processing and telecommunications from the Chalmers University of Technology. Her most recent position was at the Halmstad branch of Etteplan Sweden AB, Swedish subsidiary of the international engineering group Etteplan, where she has lead the team successfully as Department Manager, Area Manager and Teamleader. She has solid experience of project management and quality systems management, with particular expertise in medical devices.

Current Position: CTO of Redsense Medical AB

Shareholding: 0